---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-24-000138"
form_type: "8-K/A"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:29:00.863328+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GRI Bio receives Nasdaq deficiency notice for bid price below $1; 180-day cure period until March 10, 2025

## Summary
- Received Nasdaq letter on Sept 10, 2024 for failing minimum bid price of $1.00 over 30 consecutive business days.
- Has until March 10, 2025 (180 days) to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If stock closes at $0.10 or less for 10 consecutive trading days during cure period, Nasdaq may issue delisting determination.
- Company may be eligible for an additional 180-day extension if it meets other Nasdaq listing conditions.
- Management is monitoring the bid price and evaluating options to regain compliance.

## SEC filing metadata
- accession: 0001824293-24-000138
- form_type: 8-K/A
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000138/0001824293-24-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000138/val-20240910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-24-000138
- JSON: https://secwatch.observer/filing/0001824293-24-000138.json
- Plain text: https://secwatch.observer/filing/0001824293-24-000138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.